Naturally occurring benzoic acid derivatives retard cancer cell growth by inhibiting histone deacetylases (HDAC)

References

• Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Ann Rev Biochem 2001; 70:81-120; PMID: 11395403; https://doi.org/10.1146/annurev.biochem.70.1.81
   PubMed Web of Science ®Google Scholar
• Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000; 92(15):1210-6; PMID: 10922406; https://doi.org/10.1093/jnci/92.15.1210
   PubMed Web of Science ®Google Scholar
• Mottamal M, Zheng S, Huang TL, Wang G. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Molecules 2015; 20(3):3898-941; PMID: 25738536; https://doi.org/10.3390/molecules20033898
   PubMed Web of Science ®Google Scholar
• Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5(9):769-84; PMID: 16955068; https://doi.org/10.1038/nrd2133
   PubMed Web of Science ®Google Scholar
• Lobera M, Madauss KP, Pohlhaus DT, Wright QG, Trocha M, Schmidt DR, Baloglu E, Trump RP, Head MS, Hofmann GA, et al. Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group. Nat Chem Biol 2013; 9(5):319-25; PMID: 23524983; https://doi.org/10.1038/nchembio.1223
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Hao CL, Liu P, Tian X, Wang LH, Zhao L, Zhu CM. Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi1 leukemia cells. Mol Med Rep 2014; 9(2):443-9; PMID: 24297248; https://doi.org/10.3892/mmr.2013.1834
   PubMed Web of Science ®Google Scholar
• Stankov MV, El Khatib M, Kumar Thakur B, Heitmann K, Panayotova-Dimitrova D, Schoening J, Bourquin JP, Schweitzer N, Leverkus M, Welte K, et al. Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia 2014; 28(3):577-88; PMID: 24080946; https://doi.org/10.1038/leu.2013.264
   PubMed Web of Science ®Google Scholar
• Zheng L, Fu Y, Zhuang L, Gai R, Ma J, Lou J, Zhu H, He Q, Yang B. Simultaneous NF-kappaB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA In vitro and in vivo. Int J Cancer 2014; 135(7):1721-32; PMID: 24615207; https://doi.org/10.1002/ijc.28810
   PubMed Web of Science ®Google Scholar
• Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, et al. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 2007; 109(1):31-9; PMID: 16960145; https://doi.org/10.1182/blood-2006-06-025999
   PubMed Web of Science ®Google Scholar
• Mandal SM, Chakraborty D, Dey S. Phenolic acids act as signaling molecules in plant-microbe symbioses. Plant Signal Behavior 2010; 5(4):359-68; PMID:20400851; https://doi.org/10.4161/psb.5.4.10871
   PubMed Web of Science ®Google Scholar
• Anantharaju PG, Gowda PC, Vimalambike MG, Madhunapantula SV. An overview on the role of dietary phenolics for the treatment of cancers. Nutr J. 2016; 15(1):99; PMID: 27903278; https://doi.org/10.1186/s12937-016-0217-2
   PubMed Web of Science ®Google Scholar
• Zhao B, Hu M. Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells. Oncol Lett 2013; 6(6):1749-55; PMID: 24843386; https://doi.org/10.3892/ol.2013.1632
   PubMed Web of Science ®Google Scholar
• Lin HH, Chen JH, Chou FP, Wang CJ. Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-kappaB pathway and MMP-2 production by targeting RhoB activation. Br J Pharmacol 2011; 162(1):237-54; PMID: 20840540; https://doi.org/10.1111/j.1476-5381.2010.01022.x
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu Q, Liu G, Huang H, Lin W, Huang Y, Chi Z, Chen S, Lan K, Lin J, et al. Effect of histone deacetylase on prostate carcinoma. Int J Clin Exp Pathol 2015; 8(11):15030-4; PMID: 26823840
   PubMed Web of Science ®Google Scholar
• Lutz L, Fitzner IC, Ahrens T, Geissler AL, Makowiec F, Hopt UT, Bogatyreva L, Hauschke D, Werner M, Lassmann S. Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors In vitro. Am J Cancer Res 2016; 6(3):664-76; PMID: 27152243
   PubMed Web of Science ®Google Scholar
• Du L, Risinger AL, King JB, Powell DR, Cichewicz RH. A potent HDAC inhibitor, 1-alaninechlamydocin, from a Tolypocladium sp. induces G2/M cell cycle arrest and apoptosis in MIA PaCa-2 cells. J Nat Prod 2014; 77(7):1753-7; PMID: 24999749; https://doi.org/10.1021/np500387h
   PubMed Web of Science ®Google Scholar
• Karthik S, Sankar R, Varunkumar K, Ravikumar V. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells. Biomed Pharmacother 2014; 68(3):327-34; PMID:24485799; https://doi.org/10.1016/j.biopha.2014.01.002
   PubMed Web of Science ®Google Scholar
• Moreira JM, Scheipers P, Sorensen P. The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. BMC Cancer 2003; 3:30; PMID: 14606959; https://doi.org/10.1186/1471-2407-3-30
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang H, Yoon SO, Xu X, Hottiger MO, Svaren J, Nave KA, Kim HA, Olson EN, Lu QR. HDAC-mediated deacetylation of NF-kappaB is critical for Schwann cell myelination. Nat Neurosci 2011; 14(4):437-41; PMID: 21423191; https://doi.org/10.1038/nn.2780
   PubMed Web of Science ®Google Scholar
• Chen HP, Zhao YT, Zhao TC. Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog 2015; 20(1-2):35-47; PMID: 25746103; https://doi.org/10.1615/CritRevOncog.2015012997
   PubMedGoogle Scholar
• Singh BN, Zhou H, Li J, Tipton T, Wang B, Shao G, Gilbert EN, Li Q, Jiang SW. Preclinical studies on histone deacetylase inhibitors as therapeutic reagents for endometrial and ovarian cancers. Future Oncol 2011; 7(12):1415-28; PMID: 22112317; https://doi.org/10.2217/fon.11.124
   PubMed Web of Science ®Google Scholar
• Ma X, Ezzeldin HH, Diasio RB. Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 2009; 69(14):1911-34; PMID: 19747008; https://doi.org/10.2165/11315680-000000000-00000
   PubMed Web of Science ®Google Scholar
• Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol 2007; 152(1):9-20; PMID: 17549047; https://doi.org/10.1038/sj.bjp.0707305
   PubMed Web of Science ®Google Scholar
• Thurn KT, Thomas S, Moore A, Munster PN. Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer. Future Oncol 2011; 7(2):263-83; PMID: 21345145; https://doi.org/10.2217/fon.11.2
   PubMed Web of Science ®Google Scholar
• Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D, Figueroa M, Melnick A, Kao GD, Augenlicht LH, et al. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol Biol Cell 2008; 19(10):4062-75; PMID: 18632985; https://doi.org/10.1091/mbc.E08-02-0139
   PubMed Web of Science ®Google Scholar
• Lee YS, Lim KH, Guo X, Kawaguchi Y, Gao Y, Barrientos T, Ordentlich P, Wang XF, Counter CM, Yao TP. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Res 2008; 68(18):7561-9; PMID: 18794144; https://doi.org/10.1158/0008-5472.CAN-08-0188
   PubMed Web of Science ®Google Scholar
• Somprasong Saenglee SJ, Patanathai Aran, Senawong Thanaset. Cytotoxic effects of peanut phenolic compounds possessing histone deacetylase inhibitory activity on human colon cancer cell lines. Turk J Biol 2016; 40:1258-71; https://doi.org/10.3906/biy-1601-23
   Web of Science ®Google Scholar
• Waldecker M, Kautenburger T, Daumann H, Busch C, Schrenk D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 2008; 19(9):587-93; PMID: 18061431; https://doi.org/10.1016/j.jnutbio.2007.08.002
   PubMed Web of Science ®Google Scholar
• Shao Y, Gao Z, Marks PA, Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 2004; 101(52):18030-5; PMID: 15596714; https://doi.org/10.1073/pnas.0408345102
   PubMed Web of Science ®Google Scholar
• Karthik S, Sankar R, Varunkumar K, Anusha C, Ravikumar V. Blocking NF-kappaB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species. Biomed Pharmacother 2015; 69:337-44; PMID:25661379; https://doi.org/10.1016/j.biopha.2014.12.023
   PubMed Web of Science ®Google Scholar
• Lee JH, Choy ML, Ngo L, Foster SS, Marks PA. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. Proc Natl Acad Sci U S A 2010; 107(33):14639-44; PMID: 20679231; https://doi.org/10.1073/pnas.1008522107
   PubMed Web of Science ®Google Scholar
• Rosato RR, Almenara JA, Maggio SC, Coe S, Atadja P, Dent P, Grant S. Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions. Mol Cancer Ther 2008; 7(10):3285-97; PMID: 18852132; https://doi.org/10.1158/1535-7163.MCT-08-0385
   PubMed Web of Science ®Google Scholar
• Yin MC, Lin CC, Wu HC, Tsao SM, Hsu CK. Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. J Agr Food Chem 2009; 57(14):6468-73; PMID: 19601677; https://doi.org/10.1021/jf9004466
   PubMed Web of Science ®Google Scholar
• Chan FK, Moriwaki K, De Rosa MJ. Detection of necrosis by release of lactate dehydrogenase activity. Methods Mol Biol 2013; 979:65-70; PMID: 23397389; https://doi.org/10.1007/978-1-62703-290-2_7
   PubMedGoogle Scholar
• Urrego D, Tomczak AP, Zahed F, Stuhmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci 2014; 369(1638):20130094; PMID: 24493742; https://doi.org/10.1098/rstb.2013.0094
   PubMed Web of Science ®Google Scholar
• Sellers WR, Fisher DE. Apoptosis and cancer drug targeting. J Clin Invest 1999; 104(12):1655-61; PMID: 10606616; https://doi.org/10.1172/JCI9053
   PubMed Web of Science ®Google Scholar
• Shi Y. Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci 2004; 13(8):1979-87; PMID: 15273300; https://doi.org/10.1110/ps.04789804
   PubMed Web of Science ®Google Scholar
• McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2015; 7(4); PMID: 25833847; https://doi.org/10.1101/cshperspect.a026716
   PubMed Web of Science ®Google Scholar
• Silva G, Cardoso BA, Belo H, Almeida AM. Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms. PloS One 2013; 8(1):e53766; PMID: 23320102; https://doi.org/10.1371/journal.pone.0053766
   PubMed Web of Science ®Google Scholar
• Bressi JC, Jennings AJ, Skene R, Wu Y, Melkus R, De Jong R, O'Connell S, Grimshaw CE, Navre M, Gangloff AR. Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides. Bioorg Med Chem Lett 2010; 20(10):3142-5; PMID: 20392638; https://doi.org/10.1016/j.bmcl.2010.03.091
   PubMed Web of Science ®Google Scholar
• Wu G, Robertson DH, Brooks CL, 3rd, Vieth M. Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm. J Compu Chem 2003; 24(13):1549-62; PMID: 12925999; https://doi.org/10.1002/jcc.10306
   PubMed Web of Science ®Google Scholar
• Brown RE, Jarvis KL, Hyland KJ. Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem 1989; 180(1):136-9; PMID: 2817336; https://doi.org/10.1016/0003-2697(89)90101-2
   PubMed Web of Science ®Google Scholar
• Senawong T, Misuna S, Khaopha S, Nuchadomrong S, Sawatsitang P, Phaosiri C, Surapaitoon A, Sripa B. Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: sinapinic acid acts as HDAC inhibitor. BMC Complement Altern Med 2013; 13:232; PMID: 24053181; https://doi.org/10.1186/1472-6882-13-232
   PubMed Web of Science ®Google Scholar
• Madhunapantula SV, Desai D, Sharma A, Huh SJ, Amin S, Robertson GP. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma. Mol Cancer Ther 2008; 7(5):1297-308; PMID: 18483317; https://doi.org/10.1158/1535-7163.MCT-07-2267
   PubMed Web of Science ®Google Scholar
• Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82(13):1107-12; PMID: 2359136; https://doi.org/10.1093/jnci/82.13.1107
   PubMed Web of Science ®Google Scholar
• Shailasree S, Venkataramana M, Niranjana SR, Prakash HS. Cytotoxic effect of p-Coumaric acid on neuroblastoma, N2a cell via generation of reactive oxygen species leading to dysfunction of mitochondria inducing apoptosis and autophagy. Mol Neurobiol 2015; 51(1):119-30; PMID: 24760364; https://doi.org/10.1007/s12035-014-8700-2
   PubMed Web of Science ®Google Scholar
• Hrgovic I, Doll M, Kleemann J, Wang XF, Zoeller N, Pinter A, Kippenberger S, Kaufmann R, Meissner M. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. BMC Cancer 2016; 16(1):763; PMID: 27716272; https://doi.org/10.1186/s12885-016-2807-y
   PubMedGoogle Scholar
• Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35(4):495-516; PMID: 17562483; https://doi.org/10.1080/01926230701320337
   PubMed Web of Science ®Google Scholar